VHT – Volpara Health Technologies

Volpara’s ARR now stands at NZ$6.63m, compared to NZ$3.6m at the end of FY18 — an increase of 86% and above the market guidance of 85%. Total Contract Value (TCV), which represents the value of contracts signed in the specified period, totalled NZ$15.8m — an increase of 42% on FY18.

In addition, approximately 7.1% of all women screened in the United States (approximately 2.8 million women) are now contracted to Volpara’s software, compared to the target of 7%.

Be the first to comment

Leave a Reply

Your email address will not be published.